Abstract
Background Following ART initiation, a spectrum of HIV-associated immune reconstitution inflammatory syndrome (IRIS), as opportunistic infections occurs, presenting as either paradoxical or unmasking IRIS. There are benefits of ART for maternal health and prevention of perinatal transmission, however, some risks may be possible with IRIS. The study sought to estimate the incidence, compare survival times to, and investigate the baseline clinical predictors of HIV-1 paradoxical and unmasking IRIS as well as identify the homogeneity defined by combinations of specific covariates in Art Naïve Pregnant Women.
Methods A prospective, active records observational study [P609/08/-2018-E] was conducted among ART-naive pregnant women attending antenatal care unit (ANCu) from Kenyatta National and Mbagathi Hospitals in Kenya. Participants enrolled were between the ages of 20 - 49 years with a clear documentation of HIV status and, an independent review committee adjudicated IRIS diagnosis. Associations between baseline pre-ART characteristics, biomarkers, and IRIS diagnosis were assessed with Cox models. Decision-tree analysis was finally performed to identify homogeneity defined by combinations of specific parameters.
Results Of the initial total 532 women, (24.8%) (n=133) participants experienced IRIS by the 12th week post ART initiation, 27.3 % (n= 36) and 72.7% (n = 96) paradoxical and unmasking respectively. Maternal Basal Metabolic Index (MBMI) of (25 -29.9) significantly predicted unmasking IRIS [(β)=0.907, Wald test (β^) = 6.550, (HR = 2.478, 95% C.I 1.237 – 4.965, P = 0.010] same case to gravidity of above 5 [(β)=0.743, P = 0.338] while that of 2-3 predicted paradoxical IRIS [(β)= - 0.542, P = 0.037. WHO-HIV clinical stage 1 and 2 showed a link towards paradoxical IRIS, [(β)=- 0.111 and (β)= - 0.276 (P < 0.05)], clinical stage 4 with unmasking IRIS [(β)= 0.047, HR = 1.048, P = 0.941]. CD4 count > 500 cells/mm3 skewed towards unmasking IRIS diagnosis [(β)= 0.192, HR = 1.211, P = 0.416], while RNA-HIV viral loads > 50 copies/ml towards paradoxical IRIS [(β)= - 0.199, HR = 0.820, P = 0.360. On decision tree analysis, 76% (P = 0.729) of ART naïve pregnant women aged 20-29 and 40-49 years of age presented with unmasking IRIS and a gravidity of 4-5 and 1 predicted 88% (P = 0.045) unmasking IRIS as compared to that of 2-3 62 % (P = 0.045).
Conclusion Unmasking IRIS was the common type of IRIS post-ART initiation. Maternal BMI and RNA-HIV viral loads level predicted paradoxical IRIS while the baseline CD4 count and WHO-HIV clinical infection stage 1 and 4 were associated with unmasking IRIS. Gravidities of 1 and 4 – 5 predicted unmasking IRIS.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Kenya Medical Training College, partaially
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the Kenyatta National Hospital-University of Nairobi(KNH-UoN), Nairobi, Kenya, gave ethical approval for this work [Approval # P609/08/2018]
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
